Dear ECLLA Members,
Following our previous ECLLA Club sessions, we are pleased to announce our next educational opportunity, “Treatment Literacy & Shared Decision-Making in CLL”.
This session brings together Prof. Kostas Stamatopoulos, Haematologist and Research Director at the Institute of Applied Biosciences, Centre for Research and Technology Hellas (INAB-CERTH), Thessaloniki, Greece, and Dr Christina Karamanidou, Health Psychologist and Head of the Psychology Lab at INAB-CERTH.
Building on the CLL Patient Empowerment project, the Expert Panel Discussion will explore shared decision-making, treatment access constraints across Europe, patient preferences and quality of life priorities, and the role of healthcare professionals and patient organisations in supporting meaningful patient involvement, followed by an interactive Q&A.
The discussion will be moderated by Jan Rynne, ECLLA Co-Founder and Association Development Lead.
Date: Thursday, 3rd December, 3:00 – 4.30 PM CET
Format: Online (Zoom)
Duration: 90 minutes | 1 h, 30 m
Session Agenda: Download HERE
SESSION OVERVIEW
The session will focus on the following 4 interconnected areas:
- Key lessons from the CLL Patient Empowerment project and approaches that could be applied more widely across Europe;
- Shared Decision-Making across the CLL treatment pathway, from active monitoring to modern targeted therapies;
- Treatment access constraints, patient preferences and quality-of-life priorities in treatment decisions, including how differences in access and healthcare practices shape treatment choices;
- The role of patients and healthcare professionals in treatment decisions, and how patient organisations can help people with CLL participate more confidently and meaningfully in discussions about their care.
This session aims to strengthen understanding and capacity to support meaningful patient involvement in CLL treatment decisions.
With no limit to participation from each member organisation as part of your ECLLA Club Exclusive Benefit, we welcome your entire patient advocacy teams to join this session.
We look forward to continuing the ECLLA Club programme with you and to another engaging and practical session bringing together clinical expertise, research insights and patient advocacy perspectives.
Exclusive ECLLA Club Benefit
Participation in this session is provided free of charge as part of your ECLLA Club membership.
Membership in the ECLLA Club provides access to all educational sessions within the programme, expert-led learning opportunities, session recordings, multilingual resources, and a growing library of member-exclusive educational content via designted member access on the ECLLA website.
Not an ECLLA Club member yet? Join ECLLA to access the full Club programme and exclusive member resources. Learn more about the ECLLA Club and its objectives here: ECLLA Club Information Page
We look forward to learning together!
Kind regards,
Sandra Bugarski
ECLLA Club Coordinator
We would like to thank the following ECLLA foundational funders for their support of this initiative:
Join ECLLA and be part of a European community working together to improve care and equity for people living with CLL.
